Kudakwashe R. Chikwava, MD

Dr. Chikwava is a board-certified pediatric pathologist with extensive experience in diagnosing a wide range of diseases and conditions that affect children from before birth to adulthood, including cancers, genetic disorders and infectious diseases. He works in tandem with physicians throughout Texas Children’s to provide accurate and timely diagnoses, which are crucial for determining the most effective treatment options for patients.  

Dr. Chikwava is passionate about using his expertise to improve the lives of children and their families. He has coauthored numerous articles in leading medical journals and regularly shares his knowledge by teaching and mentoring students and young professionals.       

Personal Statement

I look at every specimen as if it were from my own daughter. Because clinicians depend on the information I provide them to guide treatment, I strive to anticipate their questions and needs. These practices were shaped in me by my teachers before me; therefore, I close the loop when I inspire and teach students, especially underrepresented minorities. 

Education

,

,

,

,

Organizations

,

,

,

,

,

* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.

Ladipo JE, He Z, Chikwava K, Robbins K, Beri J, Molle-Rios Z. Oncostatin-M Does Not Predict Treatment Response in Inflammatory Bowel Disease in a Pediatric Cohort. Journal of Pediatric Gastroenterology and Nutrition. 2021 Sept;73(3):352-357

Aguado A, Dunn SP, Averill LW, Chikwava KR, Gresh R, Rabinowitz D, Katzenstein HM. Successful use of transarterial radioembolization with yttrium-90 (TARE-Y90) in two children with hepatoblastoma. Pediatric Blood and Cancer. 2020 Jun 30:e28421.

Noti M, Wojno ED, Kim BS, Siracusa MC, Giacomin PR, Nair MG, Benitez AJ, Ruymann KR, Muir AB, Hill DA, Chikwava KR, Moghaddam AE, Sattentau QJ, Alex A, Zhou C, Yearley JH, Menard-Katcher P, Kubo M, Obata-Ninomiya K, Karasuyama H, Comeau MR, Brown-Whitehorn T, de Waal Malefyt R, Sleiman PM, Hakonarson H, Cianferoni A, Falk GW, Wang ML, Spergel JM, Artis D. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nature Medicine. 2013 Aug;19(8):1005-13

Chikwava KR, Hunt JL, Mantha GS, Murphy JE, Jaffe R. Analysis of loss of heterozygosity in single-system and multisystem Langerhans' cell histiocytosis. Pediatric and Developmental Pathology. 2007 Jan-Feb;10(1):18-24

Chikwava K, Jaffe R. Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders. Pediatric and Developmental Pathololgy 2004 Nov-Dec;7(6):607-14

View PubMed Publications

View Google Scholar Publications